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Abstract
Recent advances in three-dimensional bioprinting technology have led to various attempts in
fabricating human tissue-like structures. However, current bioprinting technologies have limitations
for creating native tissue-like structures. To resolve these issues, we developed a newpre-set extrusion
bioprinting technique that can create heterogeneous,multicellular, andmultimaterial structures
simultaneously. The key to this ability lies in the use of a precursor cartridge that can stably preserve a
multimaterial with a pre-deﬁned conﬁguration that can be simply embedded in a syringe-based
printer head. Themultimaterial can be printed andminiaturized through amicro-nozzle without
conspicuous deformation according to the pre-deﬁned conﬁguration of the precursor cartridge.
Using this system,we fabricated heterogeneous tissue-like structures such as spinal cords, hepatic
lobule, blood vessels, and capillaries.We further obtained a heterogeneous patternedmodel that
embedsHepG2 cells with endothelial cells in a hepatic lobule-like structure. In comparisonwith
homogeneous and heterogeneous cell printing, the heterogeneous patternedmodel showed awell-
organized hepatic lobule structure and higher enzyme activity of CYP3A4. Therefore, this pre-set
extrusion bioprintingmethod could bewidely used in the fabrication of a variety of artiﬁcial and
functional tissues or organs.
1. Introduction
Complex biological systems such as the human body
are organized into hierarchical structures, with various
cells arranged in tissues, organs, and ﬁnally the whole
organism [1]. Thus, to fabricate mature three-dimen-
sional (3D) tissues, biomanufacturing tools should be
designed so as to be able to generate various multiscale
structures. Toward this end, variousmultiscale assem-
bly strategies have been developed based on self-
assembly, guided assembly, and direct assembly strate-
gies. However, most of these methods are still in the
developmental stage with several challenges remaining
in terms of assembly efﬁciency, speed, andmechanical
stability [2]. In this context, 3D bioprinting technolo-
gies have recently emerged as attractive biomanufac-
turing tools with advantages of speed and convenience
to effectively handle a wide diversity of cell types and
biomaterials.
Dramatic advances in 3D bioprinting technologies
have enabled the fabrication of artiﬁcial and func-
tional tissues or organs owing to their versatility in
terms of precise printing for the spatial positioning/
patterning of each component on demand and the
wide selectivity of biomaterials/biomolecules and
cell types [3–5]. Therefore, these technologies have
been applied in various biomedical engineering
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and representative bioprinting technology, offers great
ﬂexibility for printing various materials (e.g., synthetic
polymers and viscous bioinks) and allows for the crea-
tion of complex 3D structures. However, one of the
drawbacks of this technology is that the cells extruded
through the nozzle of the small diameter can be
damaged by shear stress [9]. To overcome this limita-
tion, a nozzle with a larger diameter has been used to
reduce the shear stress. However, this diminishes its
printing precision [10].
An additional challenge in fabricating complex
and sophisticated 3D microstructures is that various
materials need to be printed with elaborate patterns;
hence, the current extrusion-based bioprinters
employ multiple printing heads for the fabrication of
complex biological structures [11–13]. However, an
increased number of printing heads requires a more
complex printing system and a long fabrication time.
For these reasons, several research groups have applied
microﬂuidics to bioprinting, which simultaneous dis-
penses multiple materials for the fabrication of more
precise microstructures [7, 12–14]. Similarly, micro-
ﬂuidic-based spinning techniques with continuous
coaxial ﬂow have been developed to create ﬁbrous tis-
sue structures. These structures have a higher resolu-
tion than the current extrusion-based printing
methods [15–18]. However, despite the many advan-
tages of microﬂuidic bioprinting, it requires reservoirs
with ﬂuid controllers for each material and low-visc-
osity bioinks to reduce shear stress. Furthermore,
because this technology is substantially based on con-
tinuous ﬂow, the dispensed material needs to be soli-
diﬁed in situ at the end of the nozzle [7, 14, 16, 19–21].
Human tissues are extremely heterogeneous and
comprised of different cells [22]. In particular, the
hepatic lobule in the human liver tissue is a building
block of the liver parenchyma, consisting of a portal
triad, hepatocytes arranged in the liver cord within a
sinusoid network, and a central vein. The cross-
sectional diameter of a hepatic lobule is approxi-
mately 1 mm, while the diameter of the sinusoid is
approximately several tens of micrometers, and the
size of the whole liver is several tens of centimeters
[23]. Therefore, a printing technique for the liver
tissue should be able to reproduce structures at a wide
size range from the micrometer to centimeter scale.
Current precision bioprinting methods such as
inkjet-based printing [24] and laser-assisted printing
[25] have high-resolution; however, their applic-
ability to the fabrication of large organs is limited. By
contrast, while extrusion-based printing can help
fabricate human-scale tissues [6], its resolution is not
sufﬁciently high to reproduce microscale structures
such as the sinusoid.
In this study, we developed a pre-set extrusion bio-
printing method that allows for the in situ fabrication
of heterogeneous artiﬁcial tissue-like structures. Var-
ious structures such as the spinal cord, hepatic lobule,
capillary, blood vessels, and even an ‘S’-shaped object
were fabricated heterogeneously to conﬁrm the feasi-
bility of pre-set extrusion bioprinting.Moreover, a tet-
ramerous structure was fabricated by both pre-set
extrusion and conventional bioprinting to compare
cell viability with the two techniques. Further, endo-
thelial cells (ECs) and HepG2 cells were hetero-
geneously co-printed by pre-set extrusion bioprinting,
and the cell viability, proliferation, and enzyme activ-
ity of CYP3A4 in both groups (homogeneous or het-
erogeneous cell printing)were evaluated in parallel.
2.Materials andmethods
2.1.Materials
Sodium alginate (medium viscosity) and calcium
chloride (anhydrous) were purchased from Sigma-
Aldrich. Fluorescent particles (R0200B, G0200B,
B0200; 2.0 μm, 2.0 μm, and 2.1 μm, respectively) and
the LIVE/DEAD Viability/Cytotoxicity kit (L3224)
were obtained from Fisher Scientiﬁc (UK). Lyophi-
lized Atelo-collagen (Matrixen-PSP) derived from the
porcine tendonwas purchased fromSKBioland (South
Korea).
Various precursor cartridges with speciﬁc patterns
of tetramerous shape, spinal cord, hepatic lobule,
blood vessels, and the letter ‘S’ were designed using
SolidWorks software (Dassault Systems, Vélizy-Villa-
coublay, France). The designs were then converted to
STL-ﬁles and imported into commercial 3D printing
system software for prototyping (ideaMaker, Shanghai
Fusion Technology, China). Finally, various precursor
cartridges were fabricated. The diameter of the tetra-
merous precursor cartridge was 9.3 mm, to ﬁt into
3 ml syringes, and the other cartridges were 15 mm in
diameter, to ﬁt into a 10 ml syringe. The height of the
tetramerous precursor cartridge was 15 mm and that
of the other cartridges was 20 mm.
2.2. Bioink characterization and preparation
2.2.1. Alginate solutions
Solutions of 2.0%, 3.0%, and 4.0% (w/v) sodium
alginate (viscosity2000 cP, 25 °C) in distilled water
were prepared and stirred for 24 h at 25 °C. Sequen-
tially, the alginate solution was blended with red,
green, and blue ﬂuorescent particles, or without
ﬂuorescent particles. To visualize the myriad of tissue
structures, the ﬂuorescent particle-blended alginate
solution was added to the empty segment of the
cartridge, and then placed into the syringe. From this
mixture, each ﬂuorescent particle-blended alginate
solution was simultaneously reprinted into a 200 mM
CaCl2 bath for solidiﬁcation. The reprinted struts were
then subjected to laser-scanning confocal microscopy
(FV 1200, Olympus, Tokyo, Japan) by z-stacking
(30 μm intervals) and reconstructed using laser-scan-
ning confocal microscopy software. Using the same
method as described in the preceding paragraph, the
ﬂuorescent particle-blended alginate solution was
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used for creating a lattice and block structure with
layer-by-layer printing (ﬁgure 1(d)). The 2% and 4%
alginate solutions were also used to demonstrate the
applicability of our method with a wide range of
viscous materials. The experimental details are shown
in supplementary ﬁgure S1 is available online at stacks.
iop.org/BF/10/035008/mmedia.
2.2.2. Collagen solutions
Tocreate aneutral collagen solution (pH7.4), a collagen
solution (pH 4.0) was mixed with 10X Dulbecco’s
modiﬁed Eagle medium (DMEM) solution and recon-
stituted buffer (2.2 g NaHCO3, 4.77 g HEPES, 0.2 g
NaOH in 100ml distilled water) at a volume ratio
of 8:1:1. The neutralized collagen (5% w/v) was
Figure 1. (a)A schematic illustration of pre-set extrusion bioprinting technique. (b)Experimental demonstration of pre-set extrusion
bioprinting with a tetramerous precursor cartridge ﬁlledwith alginate solution labeledwith ﬂuorescent particles (R+G+B) and
particle-free alginate solution (N). Cross-sectional view of tetramerous printing is shown in inset. (c)The average intensity proﬁle of
the central part of the cross-sectional view (denoted as dotted line in the inset ofﬁgure 1(b)). (d)A lattice structurewith the same
conditions as those in the example of tetramerous printing (R+G+B+N), shown as themiddle layer of the 2D top view (inset)
and 3D view. (e)Ablock structure built under a predesigned condition (1R+3G) via pre-set extrusion bioprinting, shown as the
middle layer of the 2D top view (inset) and 3D viewwith vertically and horizontally stacked images.
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mixed with HepG2 cells (HB-8065, American type
culture collection (ATCC), USA) at a density of 3 ×
107 cells ml−1 and EA.hy 926 cells (CRL-2922, ATCC,
USA) at a density of 2 × 107 cells ml−1. The ﬁnal
concentration of cell-laden collagen was 3%. For
pre-gelation of collagen, the bioink (e.g., cell-laden
collagen) was printed onto DMEM with 10% fetal
bovine serum (FBS) and 5% penicillin/streptomycin
at 37 °C for 1 h, and then cut by surgical blade and
moved to a 24-well culture plate. The diameter of the
bioprinted constructs was approximately 600 μm and
the lengthwas approximately 10 mm.
Rheological properties of the various alginate solu-
tions and collagenwith orwithout cells weremeasured
using a Kinexus Pro+rheometer (Malvern, Worces-
tershire, UK) equipped with a geometric cone plate
with a 20 mm diameter (PU20 SR3650 SS) and 1 mm
gap. To prevent the gradual gelation of collagen, rheo-
logical analysis of collagen was performed at 4 °C,
whichwas same as the printing temperature.
2.3. Fluorescent intensity analysis
The surface intensity proﬁle from cross-sectional
images of the myriad bioprinted constructs was
analyzed using Matlab R2011a. In particular, to
visualize two-dimensional surface images, red, green,
and blue ﬂuorescent intensities were normalized
equally.
2.4.Miniaturization of tetramerous printing
To assess the degree ofminiaturization (the percentage
ratio of a single strut to a quarter of a strut) in a single
strut of tetramerous printing, various nozzle sizes were
tested. The cross-sectional view was obtained from
z-stacked images (intervals of 30 μm) using laser-
scanning confocal microscopy. The whole area of the
strut, including the red, green, and blue ﬂuorescent
particles and the particle-free alginate solution, was
deﬁned as a single strut, and the area of one of the red,
green, or blue ﬂuorescent particles was deﬁned as a
quarter of a strut.
For precise comparison of the diameter between a
single strut and a quarter of a strut, the hydraulic dia-
meter, i.e., the equivalent diameter for an uneven-
shaped strut, was applied. The hydraulic diameters of
the single and quarter of a strut could then be directly
compared. An example of this methodology and its
application are shown in supplementary ﬁgure S2.
2.5. Cell culture
The NIH/3T3 (CRL-1658, ATCC, USA), HepG2, and
EA.hy 926 cell lines were obtained from the ATCC and
cultured in DMEM (Gibco, UK) supplemented with
10% FBS (Gibco, UK) and 1% penicillin/streptomy-
cin (Gibco, UK) at 37 °C under 5% CO2. When the
cells reached conﬂuence, they were detached from the
culture dish using 0.25% trypsin (Thermo Fisher,
USA) and then blended with the prepared alginate
solutions at room temperature or prepared collagen
on ice before bioprinting.
2.6. Cell viability
To assess cell viability, the cell-laden alginate solution
was placed into printer head. After printing, the live/
dead assay was conducted to determine the cell
viability using calcein AM and ethidium homodimer-
1. The live and dead cells were captured by laser-
scanning confocal microscopy with z-stacking (30 μm
intervals). At least 10 randomly selected areas of
each sample were used to analyze cell viability
(ﬁgures 3(d), (e)).
In the experimental group of haptic lobule print-
ing, the cell-laden collagen was cut by a surgical blade
(approximately 1 mm) to visualize cross-section of
printed strut. The live/dead assay was then performed
as described above (ﬁgure 5(c)).
2.7. Cell proliferation
Cell proliferation was measured using Cell Counting
Kit-8 (CCK-8; Dojindo Molecular Technologies,
USA), as described previously [26]. In brief, the
bioprinted strut was exposed to fresh culture medium
and CCK-8 reagent at a ratio of 10:1 after incubation
for 1, 3, and 5 d. The absorbance was thenmeasured at
a wavelength of 450 nmusing amultimodemicroplate
reader (Bioteck, USA).
2.8. Enzyme activity of CYP3A4
The CYP3A4 activity was evaluated using the P450-
GloTM CYP3A4 assay kit (Promega, USA) according
to the manufacturer’s instructions. The bioprinted
constructs were treated with rifampicin (25 μM) for
6 h for induction and were then medium-aspirated.
The bioprinted construct was incubated with culture
medium supplemented with 50 μM CYP3A4 sub-
strates. At 1 h after treatment, 50 μl of the culture
medium was removed and activity of the sample was
assayed in a luminometer.
2.9. Immunoﬂuorescence staining
Immunoﬂuorescence staining was applied to visualize
cellmorphology using 4′,6-diamidino-2-phenylindole
(DAPI; D1306, Invitrogen, USA), phalloidin Alexa
Fluor 594 (A34055, Invitrogen, USA), phalloidin Aelxa
Fluor 488 (A12379, Invitrogen, USA) and cluster of
differentiation 31 (CD31) primary antibody (ab9498,
Abcam,UK).
After culture for 1, 3, and 5 d, we used immuno-
ﬂuorescence staining (DAPI, phalloidin) to observe
the surface of printed collagen constructs (ﬁgure 5(d)):
each construct was ﬁxed in ice cold 4% paraformalde-
hyde (WAKO, Japan) and rinsed with PBS. The ﬁxed
constructs were permeabilized with 0.2% Triton-X
100 for 10 min, and then sequentially stained with
phalloidin (green) andDAPI (blue).
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Likewise, to observe the cross-section of printed
collagen constructs (ﬁgure 5(e)), the sample was cut by
surgical blade (approximately 1 mm). The ﬁxed and
permeabilized constructs were then blocked with 1%
bovine serum albumin (BSA,GenDEPOT) and immu-
nostained using a primary antibody against CD31
(1:200) for 1 h. The samples were incubatedwithAlexa
Fluor 488 goat anti-mouse (1:500) for CD31 for 1 h.
All samples were counterstained with DAPI (blue) and
phalloidin (red) and visualized using a laser-scanning
confocalmicroscope.
To visualize the overall structure of the bioprinted
strut, the EA.hy 926 cells were stained with Cell
Tracker Red CMTPX Dye (C34552, Invitrogen, USA)
and HepG2 cells were stained with Cell Tracker Green
CMFDA Dye (C2925, Invitrogen, USA). Both cell
types were blended with collagen, and then placed in
the printer head. After printing, the constructs were
captured by laser-scanning confocal microscopy with
z-stacking (30 μm intervals) (ﬁgure 5(b)).
2.10. Statistical analysis
Three independent replicates were performed for all
experiments. The statistical software SPSS 18.0 (SPSS
Inc., Chicago, IL, USA)was used for data analysis. Data
are expressed as the mean±standard deviation.
Signiﬁcant differences were assessed by a non-
parametricMann–WhitneyU test. A value of p<0.05
was judged as a statistically signiﬁcant difference.
3. Results and discussion
3.1. Pre-set extrusion bioprinting
As shown in ﬁgure 1, we ﬁrst designed and fabricated
the precursor cartridge, which is compartmentalized
into several segments, using a commercial 3D printing
apparatus (ﬁgure 1; Step 1). The cross-sectional shape
of the precursor cartridge can bemanipulated freely to
allow for versatile shapes and structures. Second, each
cartridge was ﬁlled with different types of bioinks as
desired (Step 2) and placed into a syringe (Step 3). The
multiple materials (i.e., multiple bioinks) were
extruded through the printing nozzle and three-
dimensionally materialized, with the same cross-
sectional shape as that of the precursor cartridge (Step
4). In addition, the singlemultimaterial struts could be
stacked to create the intended large-scale tissue
structures (Step 5). Thus, the key element of our new
strategy is the adoption of a precursor cartridge, which
is designed toﬁt into a printer headwith compartmen-
talization for the multiple bioinks. When the bioinks
are extruded through a small nozzle, the cross-
sectional shape is miniaturized three-dimensionally,
and is able to well-retain the initial shape. This
technique is based on thewell-established concept that
ﬂuids with a small Reynolds number do not mix easily
andmaintain their originalﬂowpatterns [12, 27].
As a proof-of-concept of the applicability of this
technique, we ﬁrst employed a tetramerous cartridge
consisting of a 3% w/v alginate solution, containing
three different ﬂuorescent particles (red (R), green (G),
and blue (B)) and a particle-free alginate solution (N),
respectively, ﬁlled into each segment. The alginate
solution was then dispensed into 200 mM calcium
chloride (CaCl2) through the nozzle. The single strut
(R+G+B+N) could be dispensed while main-
taining the tetramerous shape (ﬁgures 1(b), (c)). Simi-
lar results were obtained with various viscosities of the
bioink (supplementary ﬁgure S1).We also successfully
created a 3D construct of a simple square lattice
(R+G+B+N) and a multilayer block structure
(1R+3G) (ﬁgure (d), (e)).
3.2.Miniaturization of tetramerous printing
We next compared the diameters of a single strut
(R+G+B+N) and a quarter of a strut (R or G or
B), which were extruded through the nozzles with
various inner diameters (840 μm, 610 μm, 400 μm,
250 μm, and 200 μm; ﬁgure 2(a)). In addition, the
hydraulic diameter (DH=4×cross-sectional area of
strut/perimeter of strut) was applied for more precise
comparisons (supplementary ﬁgure S2). The hydraulic
diameter of the single strut (DH,S) was similar to
the nozzle size (ﬁgure 2(b)), and those of a quarter
of a strut (DH,Q) were approximately 260 μm,
211 μm, 161 μm, 111 μm, and 76 μm, respectively,
(ﬁgure 2(c)). Although the size of each printed strut
(i.e., DH,S) was signiﬁcantly different according
to the nozzle size, the degrees of miniaturization
(DH,Q/DH,S×100) were fairly consistent (≈30%)
(ﬁgure 2(d)). This result demonstrates that the pre-set
extrusion bioprinting method enhanced the printing
resolution by more than 3.3 times in this case (i.e.,
using a tetramerous precursor cartridge) compared to
the same printing conditions but without a precursor
cartridge. Therefore, the multiple bioinks in the
precursor cartridge could beminiaturized consistently
with a well-retained cross-sectional shape of the
precursor cartridge.
3.3. Comparison between conventional bioprinting
andpre-set extrusion bioprinting
We next aimed to assess the effect of nozzle size on
cell viability using nozzles of different sizes (inner
diameter (I.D.): 610, 400, 250, or 200 μm) and over
time (at 0, 15, 30, 45, 60, or 120 min after printing).
The NIH/3T3-laden bioinks were dispensed with-
out the precursor cartridge, and a live/dead assay
was performed under set conditions (i.e., different
nozzle sizes and printing times). Cell viability was
signiﬁcantly lower on nozzles of relatively smaller
sizes (250 and 200 μm) with a culture duration of
120 min than that on nozzles with larger sizes
(400 and 610 μm) (ﬁgure 3(b)). In addition, the dead
cells (red) were mostly detected at the peripheral
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area of the printed strut at 0 min (ﬁgure 3(a)),
indicating the potential for damage by wall shear
stress. As a result, the cell viability gradually
decreased with a decrease in nozzle size and an
increase in time.
Creating the same tetramerous structure
(ﬁgure 1(b)) using the conventional bioprinting tech-
niquewould require four heads (one for eachmaterial)
(ﬁgure 3(c)). Therefore, it necessarily took more time
and needed a complicated printing system. As shown
in ﬁgure 3(d), we successfully fabricated a tetramerous
structure using pre-set extrusion bioprinting (nozzle I.
D.=610 μm) and conventional bioprinting (nozzle I.
D.=250 μm). The conventional printing technique
resulted in lower cell viability than the pre-set extru-
sion bioprinting technique, which was attributed to
the difference in nozzle size (ﬁgure 3(e)). Thus, the
proposed strategy of pre-set extrusion bioprinting has
advantages that enable in situ heterogeneous multi-
material bioprinting in a simple manner, which
improves cell survival.
3.4. Applicability of pre-set extrusion bioprinting
Precise cell patterning techniques to mimic the
complicated microstructures of native tissues are
important and challenging, because only the accurate
positioning of different cell types and choice of
biomaterials can provide the adequate niche for tissue
formation [4]. We tested the applicability of our
technique for a variety of complex heterogeneous
structures such as the spinal cord, hepatic lobule,
capillaries, blood vessels, and even an ‘S’-shaped object
(ﬁgures 4(a)–(e)). As shown in the ﬁrst column in
ﬁgure 4, we designed the geometric shape of the
precursor cartridges using 3D CAD modeling based
on the various human tissues, and the letter ‘S’. The
precursor cartridge was fabricated by rapid prototyp-
ing (ﬁgure 4, second column), and then multiple
materials (e.g., bioinks) were added to ﬁll each
segment. The printed constructs were then extruded
according to the pre-deﬁned conﬁgurations: design of
precursor cartridge and material segmentation
(ﬁgure 4, third column). The surface intensity plot of
the cross-section shown in the fourth column of
ﬁgure 4 indicates that a diversiﬁed form with multiple
materials can be printed.
Among the biological structures, the spinal cord is
an irregular cylinder separated by white and gray mat-
ter, and the hepatic lobule is a heterogeneous structure
of a dense portion containing a large number of hepa-
tocytes and sinusoids. In terms of printing resolution,
a 3D structure that accurately mimics these tissues was
Figure 2. (a)Miniaturization of tetramerous printing using 200–840 μmnozzles and their precursor cartridges: cross-sectional
view of a single strut as tetramerous compartment, composed of ﬂuorescent particles in alginate solution (R+G+B+N); the
cross-sectional view is obtained from z-stacked images, which indicates the gradually decreasing size of the printed strut followed by
nozzle diameters. A single strut is indicatedwith a yellow dotted line and a quarter of a strut is indicated as awhite line in inset.
(b)Measurement of hydraulic diameters of the single strut (DH,S) and a quarter of a strut (DH,Q), i.e., one compartment. (c)Degree of
miniaturization, the percentage ratio ofDH,S toDH,Q, which indicates the ratio of theminiaturized hydraulic diameter of the printed
strut from thewhole to each compartment.
6
Biofabrication 10 (2018) 035008 DKang et al
difﬁcult to create using the conventional bioprinting
method. This is because a patterning technique must
be precise (100 μm or less) [28] while maintaining
high cell viability [29]. In demonstrating our proof-of-
concept, we have shown the ability of our method to
successfully produce heterogeneous 3D structures.
The signiﬁcance of this method is that the precursor
cartridges can formulate various sophisticated hetero-
geneous structures as desired, with a simple system
conﬁguration.
Figure 3. (a)Cell viability over time after printing using nozzles of various sizes and (b) its analysis. (c) Schematic illustration of the
comparison between pre-set extrusion bioprinting and conventional printing tomake the same structure as the tetramerous structure.
(d)–(e)Results of the comparison between pre-set extrusion bioprinting and conventional printing; live and dead cells are shown on
the left and its analysis is shown on the right.
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3.5.Hepatic lobule printing
Most biological systems are characterized by a multi-
level hierarchical structure, spanning a broad scale
ranging from the macroscopic to microscopic level
[2]. The liver is also a representative complex organ
with several interconnected structures across several
scales. In addition, the liver is responsible for drug and
toxin metabolism, which is crucial to survival. Thus,
generation of an appropriate liver model is a promis-
ing method for studying drug metabolism and toxico-
logical responses [30]. Herein, we fabricated two
different co-culture models consisting of ECs and
HepG2 cells by pre-set extrusion bioprinting (Pre-set)
or a simple cell mixing printing (Mix). A modiﬁed
design for hepatic lobule printing was also newly
developed, as shown in the Supplementary Informa-
tion (supplementary ﬁgure S3).
The results of the rheological analysis of the four
different bioinks (HepG2-laden collagen, ECs-laden
collagen, mixture-laden collagen, and collagen only)
are shown in ﬁgure 5(a). The viscosity, storage mod-
ulus (G′), and loss modulus (G″) of collagen were
slightly higher than those of cell-laden collagen
(ﬁgure 5(a)). Nevertheless, the hepatic lobule structure
was successfully fabricated (ﬁgure 5(b)). After 5 d of
culture, the viability of the cells on each construct was
still close to 90% (ﬁgures 5(c), (f)). In addition, the
proliferation of both cell types on the printed con-
structs was not signiﬁcantly changed between day 1
and day 3 (ﬁgure 5(g)). Thus, a cellular niche, i.e., the
printed constructs, was cytophilic for both cell types.
Sequentially, we found that the heterogeneous pat-
terning could facilitate the connectivity of each cell
type. As shown in ﬁgure 5(d), ECs on the Pre-set cov-
ered the surface of the collagen with cell–cell junc-
tions. However, the homogeneously mixed cells were
delayed or irregular in forming cell–cell connections.
Cross-sectional view of the printed construct showed
similar results (ﬁgure 5(e)). Furthermore, despite the
similar levels of cell viability and proliferation on both
the Mix and Pre-set, rifampicin-induced CYP3A4
activation on HepG2 cells was signiﬁcantly higher in
the Pre-set than in the Mix (ﬁgure 5(h)). Therefore,
homogeneous and heterogeneous patterned co-culture
Figure 4. (a)–(e)Application of pre-set extrusion bioprinting for various cross-sectional tissue structures (spinal cord, hepatic lobule,
capillaries, and blood vessel) and the letter ‘S’: 3DCADmodeling of cross-sectional tissue structures and photography of precursor
cartridges by rapid prototyping (diameter: 15 mm). 3D view of printed tissue analogs (R+G+B) and cross-sectional view in yellow
box inset. Yellow box in 3D view indicates surface intensity plot, and the corresponding surface intensity proﬁle is shown in the
graph (fourth column).
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did not affect cell proliferation but did inﬂuence indivi-
dual cell–cell interactions, indicating that the cellular
function can also be directly inﬂuenced by hetero-
geneous cell printing.
Taken together, these results conﬁrmed the utility
of pre-set extrusion bioprinting using both alginate
and collagen bioinks that are widely applied materials
for bioprinting. Further, a hepatic lobule construct
was successfully fabricated using pre-set extrusion
bioprinting. Overall, this study demonstrates that het-
erogeneous cell printing could improve cellular func-
tionality compared to homogeneous cell printing.
4. Conclusions
In this study, we developed a pre-set extrusion
bioprinting technique for creating artiﬁcial tissues or
organs. The concept involves the use of a precursor
cartridge, from which various cross-sectional tissue
structures such as the hepatic lobule, spinal cord,
capillaries, blood vessels, and even a letter-shaped
object can be printed. Therefore, beneﬁting from
high-resolution multimaterial printing of diverse
structures with a simple system conﬁguration, the
proposed pre-set extrusion bioprinting technique
could be used in a wide range of 3D printing
applications overcoming the key limitations of con-
ventional biofabrication technologies.
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Figure 5.Comparison of co-culturemethods between homogeneous and heterogeneous cell printing. (a)Rheological analysis of
bioinks for a hepatic lobule printing. (b)Experimental demonstration of cell printing using green ﬂuorescent-labeledHepG2 cells and
red ﬂuorescent-labeled endothelial cells (ECs) inmix and pre-set co-culture. (c) Live (green) and dead cells (red) on eachmodel.
(d)Morphological changes of eachmodel. The cell nuclei were stainedwithDAPI (blue) and the cytoskeletonwas stainedwith
phalloidin (green). Yellow arrows indicateHepG2 andwhite arrows indicate ECs. (e)Cross-sectional view of eachmodel.
Cytoskeletonwas stainedwith phalloidin (red) andCD31was stained as green. (f)Analysis of cell viability (n=10). (g)Analysis of cell
proliferation (n=3). (h)Rifampicin-induced CYP3A4 activation of eachmodel (n=3). *p<0.05.
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